Oncology Nursing Drug Handbook
Install Now
Oncology Nursing Drug Handbook
Oncology Nursing Drug Handbook

Oncology Nursing Drug Handbook

Caring for cancer patients

App Size: Varies With Device
Release Date: Jun 6, 2018
Price: Free
Price
Free
Size
Varies With Device

Written especially for nurses caring for patients with cancer, the 2020-2021 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. This essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration.

DESCRIPTION
Completely revised and updated, the 2020-2021 Oncology Nursing Drug Handbook includes separate chapters on molecular and immunologic/biologic targeted therapies. These chapters provide fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer. It also offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for drugs recently approved by the FDA.

Key Features

- Provides valuable information on effective symptom management, patient education, and chemotherapy administration.
- Completely revised and updated, includes separate chapters on molecular and immunologic/biologic targeted therapies
- Provides fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer
- Offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for recently FDA approved drugs
- New drugs include: apalutamide (Erleada™), calaspargase pegol-mknl (Asparlas™), Daunorubicin and cytarabine liposome for injection (Vyxeos®), glucarpidase (Voraxaze®), alpelisib (Piqray®), binimetinib (Mektovi®), dacomitinib (Vizimpro®), Duvelisib (Copiktra®), encorafenib (Braftovi®), erdafitinib (Balversa™), lorlatinib (Lorbrena®), anakinra (Kineret®), baricitinib (Olumiant®), sarilumab (Kevzara®), aprepitant injectable emulsion (Cinvanti®), granisetron hydrochloride extended-release injection (Sustol®), letermovir (Prevymis™), omadacycline (Nuzyra™), meropenem/vaborbactam (Vabomere™), Plazomicin (Zemdri™), baloxavir marboxil (Xofluza™), imipenem/cilastatin sodium/relebactam (Recarbrio™), eravacycline (Xerava™), delafloxacin (Baxdela™)
Show More
Show Less
Oncology Nursing Drug Handbook 3.7.2 Update
2023-10-23 Version History
- Keep your app updated to get the latest experience on your Android phones & tablets
- We want you to get notified about exclusive offers, promotions, & discounts. This updates does this directly through in-app notifications
- We have also updated our billing system with the latest Google Billing Library to ensure smoother and more secure transactions.
- Our app is now compatible with Android 13, ensuring compatibility with the latest features and improvements offered by the Android platform

~Skyscape Medpresso Inc
More Information about: Oncology Nursing Drug Handbook
Price: Free
Version: 3.7.2
Downloads: 5231
Compatibility: Android 5.0
Bundle Id: com.medpresso.Lonestar.oncondh
Size: Varies With Device
Last Update: 2023-10-23
Content Rating: Everyone
Release Date: Jun 6, 2018
Content Rating: Everyone
Developer: Skyscape Medpresso Inc


Whatsapp
Vkontakte
Telegram
Reddit
Pinterest
Linkedin
Hide